Methionine aminopeptidase (MetAP) is a metalloprotease that removes the N-terminal methionine during protein synthesis. To assess the importance of the two MetAPs in Mycobacterium tuberculosis, we overexpressed and purified each of the MetAPs to near homogeneity and showed that both were active as MetAP enzymes in vitro. We screened a library of 175,000 compounds against MtMetAP1c and identified 2,3-dichloro-1,4-naphthoquinone class of compounds as inhibitors of both MtMetAPs. It was found that the MtMetAP inhibitors were active against replicating and aged nongrowing M. tuberculosis. Overexpression of either MtMetAP1a or MtMetAP1c in M. tuberculosis conferred resistance of bacterial cells to the inhibitors. Moreover, knockdown of MtMetAP1a, but not MtMetAP1c, resulted in decreased viability of M. tuberculosis. These results suggest that MtMetAP1a is a promising target for developing antituberculosis agents.
INTRODUCTION
Mycobacterium tuberculosis (M. tuberculosis), the etiological agent of tuberculosis, is among the oldest pathogens that have affected humans globally, and the re-emergence of M. tuberculosis has become a primary public health burden (Dye, 2006; Gandhi et al., 2006; Raviglione, 2003; Zignol et al., 2006) . The rise in multidrug-resistant and extensively drug-resistant strains of M. tuberculosis has reduced the effect of current treatment options (Cole et al., 1998; Fauci, 2008; Zhang, 2005) . Thus, the development of antibiotics with novel mechanisms of action is essential to effectively treating patients with tuberculosis (TB).
Methionine aminopeptidase (MetAP) is a dinuclear metalloprotease that removes the N-terminal methionine from nascent proteins (Giglione et al., 2003; Lowther and Matthews, 2000) .
MetAP is conserved in all life forms from bacteria to humans. There are two classes of MetAPs, MetAP1 and MetAP2, which differ in the presence of an internal polypeptide insertion present within the catalytic domain of MetAP2 (Arfin et al., 1995) . Eukaryotes possess both classes, whereas prokaryotes have homologs of either MetAP1 (eubacteria) or MetAP2 (archaeabacteria) (Lowther and Matthews, 2000) . Variants of MetAP1 are further classified as MetAP1a, MetAP1b, and MetAP1c (Addlagatta et al., 2005b) , which are distinguished by the existence of an N-terminal extension in MetAP1b and MetAP1c, and a unique zinc finger domain in MetAP1b. Recently, we solved the X-ray crystal structures of the apo-and methionine-bound forms of M. tuberculosis MetAP1c (Addlagatta et al., 2005b) . The structure revealed the existence of a highly conserved proline rich N-terminal extension in MtMetAP1c that is absent in MtMetAP1a but has sequence homology with the linker region of human MetAP1 (HsMetAP1) (Addlagatta et al., 2005a) .
Genetic studies have shown that deletion of MetAP from Escherichia coli and Salmonella typhimurium is lethal (Chang et al., 1989; Miller et al., 1989) . In yeast, deletion of either metAP1 or metAP2 results in a slow-growth phenotype, whereas disruption of both genes is lethal (Chang et al., 1992; Li and Chang, 1995) . In Caenorhabditis elegans, MetAP2 is essential for germ cell development (Boxem et al., 2004) . In mammalian cells, both HsMetAP1 and HsMetAP2 have been shown to be required for cell proliferation (Bernier et al., 2005) . In particular, HsMetAP2 is essential for endothelial cell growth and angiogenesis and mediates the inhibition of endothelial cells by the fumagillin family of natural products (Griffith et al., 1997; Sin et al., 1997; Yeh et al., 2006) . Recent studies have also shown that HsMetAP1 is involved in regulating cell cycle progression in mammalian cells (Hu et al., 2006) .
The essential role of MetAPs in prokaryotes makes this enzyme an attractive target for the development of new antibiotics. In prokaryotes, where protein synthesis begins with an N-formylated methionine, peptide deformylase (PDF) catalyzes the removal of the formyl group before MetAP removes the newly unmasked N-terminal methionine (Giglione et al., 2003; Solbiati et al., 1999) . Unlike most other prokaryotes, M. tuberculosis possesses two MetAPs, MtMetAP1a and MtMetAP1c, which share about 33% sequence identity (Figure 1 ). Both MtMetAPs have less than 45% similarity to E. coli MetAP1 (EcMetAP1), less than 48% similarity to human MetAP1 (hMetAP1), and less than 30% similarity to human MetAP2 (hMetAP2). Given the presence of the two MetAP genes in M. tuberculosis, it was unclear whether inhibition of either or both MtMetAPs is sufficient to inhibit TB growth.
Recently, we and others (Zhang et al., 2009 ) characterized both MetAPs from M. tuberculosis strains CDC1551 and H37Rv, respectively. In this study, we investigated the functional importance of the two MtMetAPs using a combination of chemical and genetic approaches. We began by overexpressing and purifying the two MtMetAPs to near homogeneity from E. coli. Biochemical characterization revealed that both MtMetAPs are functional as methionine aminopeptidases in vitro. Using a high-throughput screening approach, we screened 175,000 compounds against MtMetAP1c and identified compounds with 2,3-dichloro-1,4-naphthoquinone core structure as inhibitors. We found that these inhibitors were active against both MtMetAP enzymes and mycobacterial growth in culture. In addition, we obtained genetic evidence that an MtMetAPs is likely the relevant target of the newly discovered inhibitors in M. tuberculosis in culture.
RESULTS
Overexpression, Purification, and Characterization of MtMetAP1a and MtMetAP1c A BLAST search of the genome of M. tuberculosis (Cole et al., 1998) revealed the existence of two orthologs of E. coli MetAP, and their N-terminal extension suggested that they belonged to MtMetAP1a and MtMetAP1c classes, respectively (Figure 1 ) (Addlagatta et al., 2005b) . Previously, we have succeeded in The alignment was generated using ClustalW (www.ebi.ac.uk). Both MtMetAPs share a 33% similarity, and the metal-chelating residues necessary for catalysis are conserved (*). MtMetAP1a and EcMetAP1 lack the N-terminal extension with a PXXPXP motif present in MtMetAP1c AND HsMetAP1 (underlined).
cloning, overexpressing, and purifying recombinant MtMetAP1c with an N-terminal poly-histidine tag for crystallographic studies (Addlagatta et al., 2005b) . Recombinant MtMetAP1a was overexpressed and purified in a similar manner, except that the expression vector pET-28b was used to append a C-terminal poly-His tag on the protein. Both proteins were efficiently purified to near homogeneity by immobilized metal affinity chromatography using Talon resins. Upon purification, C-terminally polyHis-tagged MtMetAP1a and N-terminally poly-His-tagged MtMetAP1c were seen at about 28 kDa and 32 kDa, respectively, on Coomassie blue-stained SDS-polyacrylamide gels ( Figures  2A and 2B) . The average yield from 1 liter of E. coli culture for MtMetAP1a and MtMetAP1c were 4.3 and 13 mg, respectively.
The enzymatic activities of the purified M. tuberculosis MetAPs were assessed using a chromogenic substrate (MetPro-pNA) in a coupled enzymatic assay with proline aminopeptidase as the coupling enzyme (Zhou et al., 2000) . Both purified recombinant proteins were found to be catalytically active in this assay ( Figure 2C ). The kinetic constants for MtMetAP1a and MtMetAP1c were determined by measuring enzyme activity at different substrate concentrations ranging from 0 to 800 mM. The K m for the artificial substrate was similar for both enzymes, whereas the k cat for MtMetAP1c was 10-fold higher than that for MtMetAP1a (Table 1) .
Using the same enzymatic assay, we also determined the effects of temperature on both enzymes (see Figure S1 available online). The temperature profile of MtMetAP1a gave a bellshaped curve, with an optimal temperature of 42 C. In contrast, the activity of MtMetAP1c increased by smaller increments as temperatures were increased from 4 C to 50 C before loss of activity was seen at 65 C. These results suggested that MtMetAP1c had a slightly higher thermostability than did MtMetAP1a. The pH profiles of both MtMetAPs were determined by measuring the enzymatic activity in different buffers. The optimal pH for both MtMetAPs was found to be 8.0 using 50 mM HEPES as buffer ( Figure S2 ). It is noteworthy that MtMetAP1a had optimal activity from pH 6.5 to pH 8.0, whereas MtMetAP1c had a much steeper decline in activity upon pH changes from 8.0.
Because the physiological metal cofactor for MetAPs remains controversial, we determined the metal dependence of the two MtMetAPs. Both MtMetAPs were found to be active in the presence of Co 2+ or Mn 2+ . For MtMetAP1c, concentration-dependent inhibition was observed in the presence of increasing amounts of CoCl 2 ( Figure S3A ). In contrast, MtMetAP1c retained its optimal activity in the presence of 0.1-10 mM of Mn
2+
, and only a slight decrease in activity was seen when Mn 2+ concentration was increased beyond 100 mM ( Figure S3B ). Unlike MtMetAP1c, MtMetAP1a showed optimal activity at 10 mM of Co 2+ ( Figure S3C ) and 0.1-1 mM of Mn 2+ ( Figure S3D ).
Identification of MtMetAP Inhibitors via High-Throughput Screening
In collaboration with ASDI Inc., we screened a structurally diverse small molecule library of 175,000 compounds against MtMetAP1c at a final concentration of 30 mM in 384-well plates using the coupled enzymatic assay (Zhou et al., 2000) . A total of 439 hits were identified that exhibited greater than 40% inhibition of MtMetAP1c at a final concentration of 10 mM. Interestingly, a number of the hits were found to contain 2,3-dichloro-1,4-napthoquinone core structure. We acquired a total of 28 structural analogs for structure-activity relationship studies (Table 2 ). For MtMetAP1a, we found that substitutions to the 2, 3-dichloro positions reduced activity, except for the 2,3-dibromo derivative (compound 20; Table 2 ). In contrast, MtMetAP1c tolerated both fluorophenoxy and dibromo substitutions to the 2,3-dichloro positions (compounds 21, 22, and 20, respectively) ( Table 2 ). In addition, we also determined the effects of some naturally occurring 1,4-naphthoquinones and vitamin K derivatives ( (Table 3 ). In addition to replicating M. tuberculosis, we also tested these MtMetAP inhibitors in aged nongrowing M. tuberculosis (Table 3) . Interestingly, the active inhibitors, compounds 4 and 20, were equally effective against the aged non-growing form of M. tuberculosis as the replicating form.
Overexpression of MtMetAP1a or MtMetAP1c Confers Resistance to M. tuberculosis to the Newly Identified MetAP Inhibitors If either of the MtMetAPs is the target of the inhibitors in vivo, it is expected that their overexpression will cause resistance. To perturb the cellular levels of MtMetAPs, we first cloned each of the mycobacterial MetAP1s into pSCW35DsigF (Figure 3 ), a vector whose promoter is regulated by acetamide (P ace ). This vector also has an attP site that allows for stable integration of a single copy of the plasmid into the attB site in the chromosome of M. tuberculosis (Raghunand et al., 2006) . The entire ORFs of MtMetAP1a and MtMetAP1c genes were amplified by PCR from M. tuberculosis strain CDC1551 genomic DNA and were then subcloned into pSCW35DsigF vector in the sense orientation. The pSCW35-(MtMetAP1a) and pSCW35-(MtMetAP1c) clones were verified by DNA sequencing.
To overexpress MtMetAP1a and MtMetAP1c in M. tuberculosis, we constructed knock-in strains for both MtMetAPs by transforming M. tuberculosis CDC1551 with pSCW35DsigF-(MtMetAP1a) and pSCW35DsigF-(MtMetAP1c), respectively. In addition, we also transformed M. tuberculosis with a control empty plasmid, pSCW35DsigF. All three transformants were grown until early logarithmic phase, and expression was induced by addition of 0.2% acetamide followed by incubation for an additional 24 hr. To confirm that the levels of both MtMetAP1s were increased, we used real-time quantitative PCR to quantitate the transcript levels of both enzymes. The mRNA levels of MtMetAP1a and MtMetAP1c were about 4.5-and 6-fold higher than that of the control, respectively ( Figure 3B ). We examined the growth of the knock-in M. tuberculosis strains in the presence of 2,3-dichloro-1,4-naphthoquinone. Both the wild-type and control M. tuberculosis strains were inhibited in the presence of 10 mg/mL 2,3-dichloro-1,4-naphthoquinone ( Figure 4 ). In contrast, both MtMetAP1a and MtMetAP1c knock-in strains gained resistance to the inhibitor (Figure 4 ), suggesting that (C) Velocity versus substrate concentration plot for MtMetAP1a (triangles) and MtMetAP1c (squares). The kinetic constants were obtained by measuring enzyme activity at different substrate concentrations. The reactions were performed in 96-well plates at room temperature and monitored at 405 nm on a UV-Vis spectrophotometer. The total volume of reaction was 100 ml (each reaction contains 40 mM HEPES [pH 7.5], 100 mM NaCl, 1 mM CoCl2, 100 mg/mL BSA, 0.1 U/mL ProAP, and 0-800 mM Met-Pro-pNA), 334 nM MtMetAP1c, and 3.29 mM MtMetAP1a, respectively. The background hydrolysis was corrected. The data were from quadruplet experiments and were fitted against the Michealis-Menten equation: V = Vmax 3 [S] / (Km + [S]), using the Graphpad prism software for one-site binding hyperbola.
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Methionine Aminopeptidases as Anti-TB Targets both MtMetAP1a and MtMetAP1c are capable of binding and sequestering the inhibitor in vivo.
Knockdown of MtMetAP1a, but Not MtMetAP1c, Led to a Decrease in Growth of M. tuberculosis It has been shown that MetAP plays an essential role in bacteria, because knockout in E. coli and other bacteria is lethal (Chang et al., 1989; Miller et al., 1989) . Because M. tuberculosis possesses two MetAP genes, it was unclear whether knocking out either or both of these genes in M. tuberculosis is sufficient to inhibit growth. To study the requirement of MtMetAP1a and MtMetAP1c for viability of M. tuberculosis, we cloned each of the mycobacterial MetAP1s in the reverse orientation downstream of the acetamide-regulated promoter (P ace ) in pSCW35DsigF ( Figure 3A) . The resulting plasmids, pSCW35DsigF-(a-MtMetAP1a) and pSCW35DsigF-(a-MtMetAP1c), were verified by sequencing. These antisense vectors, as well as the empty control vector, were used to transform M. tuberculosis. The three transformants were grown until early log phase, at which point the antisense RNA was induced by addition of 0.2% acetamide followed by incubation for an additional 24 hr. The cultures were grown for three weeks on plates in the presence and absence of acetamide. To confirm that the levels of both mycobacterial MetAP1s were altered, we used real-time quantitative PCR to determine the transcript levels of both enzymes. The mRNA levels of MtMetAP1a and MtMetAP1c were reduced by about 1.7-and 2.3-fold in comparison to that of the control ( Figure 3C ). The colony counts after three weeks (Table 4) showed that knockdown of MtMetAP1c in M. tuberculosis had a marginal effect on bacterial growth in comparison to the control, indicating that MtMetAP1c is probably not essential for M. tuberculosis growth in vitro. In contrast, knockdown of MtMetAP1a decreased the viability to 76.0% in comparison to culture expressing the control vector (Table 4) . Because MtMetAP1a was only partially knocked down and the degree to which its mRNA decreased is even less than that of MtMetAP1c, this decrease in cell viability is significant, suggesting that MtMetAP1a is likely an essential gene in M. tuberculosis and that the inhibitory effects of the newly identified inhibitors on TB growth was likely to be mediated by inhibition of MtMetAP1a.
DISCUSSION
In this study, we applied a combination of chemical and genetic approaches to investigate the functions of two isoforms of MtMetAP and gathered strong evidence that MtMetAP1a is essential for the growth of M. tuberculosis and a promising target for discovering and developing anti-TB agents. In addition, we also identified naphthoquinones as an active pharmacophore for developing inhibitors of MtMetAP1. Inhibition of MtMetAP1a by either small molecule inhibitors or expression of an antisense RNA targeting MtMetAP1a led to significant inhibition of the growth of M. tuberculosis in culture, supporting the notion that MtMetAP1a plays an essential role in M. tuberculosis.
The availability of a number of analogs of this structural class made possible a preliminary structure-activity relationship study. Among a variety fo 2.3-disubstituted naphthoquinones tested, the analogs with the highest potency contain either a chlorine (4) or bromine (20) substituent. There is also a correlation between the potencies of the analogs to inhibit MtMetAP enzymes in vitro and their ability to inhibit bacterial growth. Thus, the two most potent inhibitors of MtMetAP (4 and 20) also exhibited the lowest MIC values for inhibition of TB culture growth (Tables 2 and 3 ). Together with the antisense RNA knockdown results, these observations provide additional evidence that inhibition of mycobacterial growth is due to inhibition of the MtMetAP1a.
According to genomic sequences available to date, M. tuberculosis possesses two MetAP-encoding genes, in contrast to most other prokaryotes, which harbor only a single gene for MetAP enzyme. In a previous study, biochemical purification of MetAP enzyme from M. smegmatis yielded a single protein, calling into question whether both of the putative MetAP genes are expressed and, if so, whether they are bona fide MetAP enzymes (Narayanan et al., 2008) . Using RT-PCR, we were able to detect mRNA for both MtMetAP proteins, indicating that they are actively transcribed in M. tuberculosis. Using purified recombinant MtMetAP proteins, we demonstrated that both MtMetAP1a and MtMetAP1c are active enzymatically, even though MtMetAP1a is $10-fold less active. We note that while this manuscript was under review, Zhang et al. (2009) reported the biochemical characterization of both MetAPs from M. tuberculosis with similar observations. Where the two studies overlapped, however, there are some important differences. For example, the two MetAP proteins were found by Zhang et al. to be similar in enzymatic activity. The optimal temperature, metal ion concentrations, and pH for the recombinant proteins also differ to some extent. It is noteworthy that different assays were used in the two studies. We used a contiguous spectrophotometric assay with Met-Pro-pNA as a substrate, but Zhang et al. used methionine-containing oligopeptides as substrates (Zhang et al., 2009 ). The distinct substrates and the accompanying assay conditions may account for most, if not all, of the qualitative differences in kinetic parameters and temperature and pH dependence observed in the two studies.
The unique presence of two isoforms of MetAP enzymes in TB, in contrast to the majority of other prokaryotes, called into question whether one or both isoforms are essential for the viability of the mycobacteria. To assess this question, we performed a highthroughput screen against MtMetAP1c and identified a family of structurally related inhibitors sharing a common 1,4-napthoquinone core. Although evaluation of additional structural analogs led to the identification of more potent inhibitors of MtMetAP1c, none of the inhibitors of this structural class is selective toward either MtMetAP1c or MtMetAP1a. The lack of isoform specificity is consistent with the observation that overexpression of either MtMetAP isoform conferred resistance to the inhibitor. The nonselective MtMetAP inhibitors were capable of inhibiting V max (mM/min) 5.1 ± 0.2 7.6 ± 0.5
The assay was performed in the presence of 1 mM CoCl 2 . Details of the assay are described in Experimental Procedures.
the growth of M. tuberculosis, suggesting that either or both MtMetAP enzymes are essential for bacterial growth, leaving unanswered the question of whether the growth inhibition was mediated through one or both isoforms of MtMetAP. Using knockdown with specific antisense RNA, we found that knockdown of MtMetAP1a, rather than MtMetAP1c, slowed growth of M. tuberculosis in culture, which suggests that inhibition of MtMetAP1a may be responsible for growth inhibition by the small molecule inhibitors. However, these results are also consistent with an alternative possibility that the two MetAP1 proteins are functionally redundant and inhibition of both enzymes mediated the growth inhibition by the nonselective small molecule inhibitors. It is worth pointing out that both MtMetAP genes have been previously predicted to be essential for M. tuberculosis survival in vivo and pathogenicity (Ribeiro-Guimaraes and Pessolani, 2007) . Together with the previous observation that the two genes are optimally expressed at different growth phases of M. tuberculosis (Zhang et al., 2009) , it is possible that only MtMetAP1a is required for growth in culture medium in vitro. The presence of multiple isoforms of MetAP-encoding genes has also been seen in some other pathogenic microorganisms. For example, Bacillus anthracis possesses three putative MetAP genes, and malaria contains four different isoforms of MetAPs . In comparison to most prokaryotes, M. tuberculosis is also unique in that it has to evade and propagate within human microphages. It will be interesting to determine whether MtMetAP1c may play a role in the survival of M. tuberculosis within mammalian cells. Of the two MtMtMetAP enzymes, MtMetAP1c contains an N-terminal ''linker'' region, whereas MetAP1a is free of the N-terminal domain similar to other prokaryotic MetAP enzymes (Figure 1 ). Using nearly homogeneous recombinant proteins, we found that MtMetAP1a is catalytically 10-fold less active than MtMetAP1c. This difference in activity appeared to be due to the use of the artificial tripeptide substrate, because similar activities were found when oligopeptide substrates were used (Zhang et al., 2009 ). In addition, we also observed some difference in thermostability, optimal pH, and dependence on metal ions. In comparison with MtMetAP1c, MtMetAP1a has a lower optimal temperature, a broader range of optimal pH values spanning one unit of pH, and a higher threshold of activation by metal ions. Although MtMetAP1c contains an N-terminal SH3 ligand-containing extension, MetAP1a contains an internal insertion of six amino acids, in comparison with MetAP1c and human MetAP1. These differences in primary structure and the accompanying tertiary structures may account for part of the differences in activity, substrate specificity, and other biochemical properties of the two MtMetAPs. It also raised the possibility of identifying inhibitors that are specific for MtMetAP1a over MtMetAP1c or human MetAP1 as leads for anti-TB drugs.
SIGNIFICANCE
The emergence of multidrug-resistant and extensively drugresistant Mycobacterium tuberculosis strains has imposed a pressing need for antimycobacterials with novel mechanisms of action. Methionine aminopeptidases are evolutionarily conserved enzymes, and they play essential roles for the viability of both prokaryotes and eukaryotes. The functional importance of MetAP in M. tuberculosis, however, remained unclear, as it possesses two genes, MtMetAP1a and MtMetAP1c. By overexpressing each isoform in E. coli and purifying them to near homogeneity, we demonstrated that both recombinant MtMetAP proteins are enzymatically active. Furthermore, quantitative RT-PCR analysis revealed that both proteins are expressed, at least at the mRNA level, in stationary cell culture. Using high-throughput screening, we identified inhibitors of both enzymes, which also inhibited the growth of mycobacteria in culture. Using antisense RNA, we found that the two isoforms are not functionally redundant. Although the more active MtMetAP1c is dispensable, MtMetAP1a appears to be required for mycobacterial growth in culture. Thus, MtMetAP1a can serve as a target and the naphthoquinone-containing inhibitors can serve as leads for the development of new anti-TB agents.
EXPERIMENTAL PROCEDURES Materials
The vectors pET28a and pET28b and the E. coli BL21 expression host were purchased from Novagen. The expression vector pSCW35DsigF, a pMH94-based vector, was constructed by Dr. Sam Woolwine. The iScript cDNA synthesis kit and the SYBR Green Supermix were purchased from BioRad Laboratories. The M. tuberculosis cultures medium, Middlebrook 7H9, was purchased from Becton Dickinson. The Talon resin was from Clontech. Isopropyl b-D-thiogalactopyranoside (IPTG) was purchased from Sigma Aldrich. The structurally diverse compound library was provided by ASDI.
Subcloning of the Two MetAPs from M. tuberculosis
The N-terminal polyHis-tag MtMetAP1c gene was amplified by polymerase chain reaction (PCR) from M. tuberculosis (CDC1551) genomic DNA using Taq polymerase. The M. tuberculosis (CDC1551 strain) genomic DNA was generously provided by Dr. William Bishai. The primers used were 5 0 -GCG GGA TCC CCT AGT CGT ACC GCG CTCÀ3 0 and 5 0 -GCG CTC GAG CTA CAG ACA GGT CAG GAT C-3 0 for forward and reverse directions, respectively.
The PCR fragments were cloned into pET28a, using the BamHI and XhoI restriction sites, respectively. The C-terminal polyHis-tag MTMAP1A gene was amplified by PCR from pET28a (MtMAP1a) plasmid (this plasmid was also subcloned from M. tuberculosis genomic DNA generously provided by Dr. William Bishai). The primers used were 5 0 -GCG CCA TGG GCC CAC TGG CAC GGC TGC GGG GTCÀ3 0 and 5 0 -GCG CTC GAG ACC GAG CGT CAG AAT TCG GGG CCC-3 0 for forward and reverse directions, respectively. The PCR fragments were cloned into pET28b, using the NcoI and XhoI restriction sites, respectively. Both MtMetAP1a and MtMetAP1c clones were confirmed by sequencing. 
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Methionine Aminopeptidases as Anti-TB Targets E. coli cells (BL21) containing the expression plasmid were cultured at 37 C in 1 liter of LB containing 30 mg kanamycin until OD 600 reached about 0.6-0.7. The expression was induced by addition of IPTG to a final concentration of 1 mM followed by shaking the culture flask at 37 C, and 275 rpm for 4 hr.
The cells were harvested and washed with 13 PBS. The cells were sonicated in 1X PBS with 0.2% Triton X-100 and EDTA-free protease inhibitor tablets. The resulting cell free lysate was centrifuged at 80003 g for 10 min. The supernatant was loaded onto pre-equilibrated (13 PBS) Talon resin (Clontech). After equilibration for 30 min, the beads were washed three times with basic buffer (10 mM HEPES [pH 8.0], 100 mM KCl, 1.5 mM MgCl 2 , and 10% glycerol). The enzyme was eluted with 75 mM imidazole in basic buffer. The protein was quantified using the Bradford assay. The average yield for MtMetAP1c was 13.2 mg/l of culture.
Determination of Kinetic Constants of MtMetAPs
The kinetic constants of the mycobacterial MetAPs were determined using a coupled methionine-proline aminopeptidase assay developed by Dr. Dehua Pei at The Ohio State University (Zhou et al., 2000) . The substrate used in this assay is a dipeptide, methione-proline coupled to p-Nitroaniline. The dipeptide substrate, Met-Pro-pNA, was synthesized by Dr. Keechung Han. The kinetic constants were obtained by measuring enzyme activity at different substrate concentrations. The reactions were performed in 96-well plates at room temperature and monitored at 405 nm on a spectrophotometer. The total reaction volume was 100 ml, and each reaction contained 40 mM HEPES buffer (p.H 7.5), 100 mM NaCl, 1 mM CoCl 2 , 100 mg/mL BSA, 0.1 U/mL ProAP, 0-800 mM substrate (Met-Pro-pNA), 334 nM MtMetAP1c, and 3.29 mM MtMetAP1a, respectively. The background hydrolysis was corrected, and the data were fitted against the Michealis-Menten equation:
, using the Graphpad prism software for one-site binding hyperbola.
High-Throughput Screening for MtMetAP1c Inhibition
We screened about 175,000 compounds against MetAP1c at concentrations of 30 mM in 384-well plates, using the dipeptide substrate. The compounds were dissolved in dimethylsulfoxide (DMSO). The initial screen was conducted using a titertek instrument with liquid handling capabilities coupled to a spectrophotometer. The total reaction volume was 50 ml, and each reaction contained 40 mM HEPES buffer (pH 7.5), 100 mM NaCl, 100 mg/mL BSA, 0.1 U/mL ProAP, 1.5 mM CoCl 2 , 600 mM substrate (Met-Pro-pNA), and 252 nM MtMetAP1c. The enzyme was preincubated with compounds for 20 min at room temperature followed by addition of 600 mM substrate. The reaction was incubated at room temperature for 30 min and monitored at 405 nm on a spectrophotometer. The Compounds that showed greater than 30%-40% inhibition were chosen as ''hits.''
Determination of IC 50 of Inhibitors of MtMetAP1 and Clustering of Structural Classes of Inhibitors (ASDI-ISIS)
We determined the concentration needed for 50% inhibition in 96-well plates at final concentrations ranging from 100 mM to 300 nM (for 81 compounds that were available in larger quantities). The total reaction volume was 50 ml, and each reaction contained each MtMetAP1, respectively, and 40 mM HEPES buffer (p.H 7.5), 100 mM NaCl, 100 mg/mL BSA, 0.1 U/mL ProAP, 1.5 mM CoCl 2 , and 600 mM substrate (Met-Pro-pNA). The enzyme was preincubated with compounds for 20 min at room temperature followed by addition of substrate. The reaction was incubated at room temperature for 30 min and monitored at 405 nm on a spectrophotometer. The background hydrolysis was corrected, and the data were fitted against the sigmoidal-dose response (variable slope) equation using GraphPad prism software.
Determination of Minimum Inhibitory Concentration in M. tuberculosis
The primary screen against replicating M. tuberculosis was conducted with 14 MtMetAP inhibitors at concentrations ranging from 50 to 0.05 mg/ml. The MetAP inhibitors were serially diluted in DMSO and added to 7H9 broth and OADC (without Tween 80) to give final concentrations of 50, to 0.05 mg/ml. A culture of M. tuberculosis H37Rv was grown to an OD of 1.0, and diluted to 1/100. Then each tube containing compound was inoculated with 0.1 ml of culture to give a total assay volume of 5 ml. The controls were DMSO, Isoniazid (a positive control) and a blank (drug free media). The 15-ml conical assay tubes containing mycobacteria were incubated at 37 C and in 5% CO 2 .
Formation of granulation was monitored for two weeks.
Activity of Inhibitors on Aged Nongrowing M. tuberculosis
The primary screen against non-replicating M. tuberculosis was conducted with 21 MtMetAP inhibitors against non-replicating M. tuberculosis at concentrations ranging from 0.5 to 100 mM for three weeks. The screen against agedcultured M. tuberculosis was conducted using a persister model, as described by Byrne et al. (2007) . Briefly, a 2-month-old M. tuberculosis H37Ra culture grown in 7H9 medium (Difco) with 10% albumin-dextrose-catalase (ADC) and 0.05% Tween 80 was resuspended in acid 7H9 medium (pH5.5) without ADC. The bacterial cell suspension was used as inocula for assaying the activity of the compounds for persister bacilli. The compounds were diluted from the stock solution (10 mM in DMSO) to 10 mM (final) followed by incubation with the bacilli in 200 ml in acidic (pH 5.5) 7H9 medium without ADC in 96-well plates for 3 days without shaking under 1% oxygen in a hypoxic chamber. The assay was done in duplicate. Rifampin (5 mg/ml) was used as a positive control. After 3-day drug exposure, the viability of the bacilli was determined by adding 20 ml of 1 mg/ml XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) and incubated at 37 C up to 7 days when the plates were read at OD 485 nm.
Subcloning of MtMetAP1a and MtMetAP1c into pSCW35DsigF
The entire ORFs of MtMetAP1a and MtMetAP1c genes were amplified by polymerase chain reaction (PCR) in the sense orientation from M. tuberculosis strain CDC1551 genomic DNA. Then, we cloned the PCR fragments into pSCW35 vector, using the NdeI and PacI restriction sites. The primers used were as follows: for MtMetAP1a, forward 5 clones were verified by DNA sequencing.
Overexpression of MtMetAP1a and MtMetAP1c in M. tuberculosis in the Presence of Inhibitor
We constructed knock-in strains of both MtMetAP1s by transforming M. tuberculosis CDC 1551 with pSCW35DsigF-(MtMetAP1a) and pSCW35DsigF-(MtMetAP1c), respectively. In addition, we transformed M. tuberculosis with a control plasmid, pSCW35DsigF, which is an empty vector kindly provided by Dr. Tirumalai. All three transformants were grown until early log phase and expression was induced by addition of 0.2% acetamide followed by incubation for 24 hr. We diluted the cells to an OD 600 of 0.05 and cultured them separately in the presence of 10 mg/ml 2,3-dichloro-1,4-naphthoquinone or DMSO. Then growth was followed by recording OD 600 every 24 hr for 7 days. The M. tuberculosis cultures were grown in Middlebrook 7H9 medium and supplemented with 2% glycerol, 0.05% Tween-80, and 10% albumin/ dextrose complex (ADC).
Subcloning of Antisense of MtMetAP1a and MtMetAP1c into pSCW35DsigF
To study the requirement of MtMetAP1a and MtMetAP1c for growth and survival of M. tuberculosis, we cloned each of the mycobacterial MetAP1s in the reverse orientation downstream of the acetamide regulated promoter (P ace ) in pSCW35DsigF. The entire ORFs of MtMetAP1a and MtMetAP1c genes were amplified by polymerase chain reaction (PCR) in the antisense orientation from M. tuberculosis strain CDC1551 genomic DNA. Then, we cloned the PCR fragments into pSCW35DsigF vector, using the NdeI and PacI restriction sites. The pSCW35DsigF -(a-MtMetAP1a) and pSCW35DsigF -(a-MtMetAP1c) clones were verified by restriction digestion and DNA sequencing.
Knockdown of MtMetAP1a and MtMetAP1c in M. tuberculosis We constructed knockdown strains of both MtMetAP1s by transforming M. tuberculosis CDC 1551 with the antisense constructs: pSCW35DsigF -(a-MtMetAP1a) and pSCW35DsigF -(a-MtMetAP1c). Then, we transformed M. tuberculosis with a control plasmid, pSCW35DsigF. All three transformants were grown until early log phase, and expression was induced by addition of 0.2% acetamide for 24 hr. Then the cultures were grown for three weeks on plates in the presence and absence of acetamide. The M. tuberculosis culture plates (Middlebrook 7H10 agar) were supplemented with 5% glycerol and 10% ADC. The colony counts were conducted after three weeks, and percentage of viability was determined using the following formula: Viability % = 100 3 [number of colonies on 7H10 K15 + 0.2% acetamide / number of colonies on 7H10 K15].
Mycobacterial RNA Isolation
To confirm that the levels of both mycobacterial MetAP1s were altered as expected, we extracted RNA from the acetamide-induced transformants and used real-time quantitative PCR to quantitate the transcript levels of both enzymes, as described below. M. tuberculosis cultures containing plasmids overexpressing sense and antisense constructs of MtMetAP1a and MtMetAP1c and the control plasmid pSCW35DsigF were grown to exponential phase and induced with 0.2% acetamide for 24 hr. Following induction, cells were pelleted by centrifugation at 3000 rpm for 10 min. The pellet was washed once with PBS and resuspended in 1 ml of Trizol reagent (Invitrogen Technologies) in 2 ml O-ring tubes. Cells were lysed by eight bead beating cycles of 30 s each (with 0.1 mm silica zirconia beads; Biospec Products), on a bead beater (Biospec Products). The tubes were then centrifuged at 13,000 rpm for 5 min to recover the supernatant; the beads and cell debris were discarded at this point. Two hundred microliters of chloroform was added to the supernatant and centrifuged at 13,000 rpm for 5 min following a 30 s vortex cycle.
To precipitate the RNA, one volume of isopropanol was added to the aqueous phase, mixed, and incubated at RT for 10 min. RNA was pelleted by centrifuging at 13,000 rpm for 10 min at 4 C. The pellet was washed twice with 70% ethanol and dried at RT. The RNA samples were resuspended in DEPC water and quantitated by measuring A 260 . The quality of the RNA was assessed by the A 260 /A 280 ratio and by agarose gel electrophoresis.
Real-Time PCR Analysis
To quantitate transcript levels of MtMetAP1a and MtMetAP1c under conditions where the levels of the genes was being perturbed, RNA was isolated from the acetamide-induced cultures (as described above), treated with RNase-free DNase (Ambion) and 0.5 mg of RNA, and subjected to reverse transcription using the iScript cDNA synthesis kit (Biorad). This was followed by real-time quantitative PCR using the SYBR Green Supermix (Bio-Rad Laboratories). MtMetAP1a and MtMetAP1c were amplified using gene specific primers; both sets of primers amplify 200 nt of the respective gene. The primers used were as follows: for MtMetAP1a, forward 5 0 -CCGAGGTGCTC GCGCCCGGTG-3 0 and reverse 5 0 -TTCGATGGCATGCGCGACG-3 0 ; and for MtMetAP1c, forward 5 0 -GCTGGGCTACAAGGGATTCCCGAAG-3 0 and reverse 5 0 TCCGGTCAACGAGCAACCGGTG-3 0 . The relative fold change of mRNA of the two genes under each of the experimental conditions was measured by normalizing its transcript level to that of M. tuberculosis sigma factor A (sigA). The fold differences in transcript levels were derived by comparing the Ct values in the test (sense 1a, sense 1c, antisense 1a, and antisense 1c) samples with that of the control sample (pSCW35DsigF).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j. chembiol.2009.12.014.
